ContraFect Announces Multiple Presentations of New Data Demo

ContraFect Announces Multiple Presentations of New Data Demonstrating the Potential of Its Direct Lytic Agents (DLAs) to Address Antimicrobial Resistance at the 32nd Annual ECCMID Meeting

ContraFect Announces Multiple Presentations of New Data Demonstrating the Potential of Its Direct Lytic Agents (DLAs) to Address Antimicrobial Resistance at the 32nd Annual ECCMID Meeting
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Portugal , Lisbon , Lisboa , Dario Lehoux , Jules Abraham , Michael Messinger , Exchange Commission , Head Of Preclinical Development , Contrafect Corporation Nasdaq , European Congress , Linkedin , Contrafect Corporation , Company Breakthrough Therapy , Clinical Microbiology , Infectious Diseases , Annual Meeting , Breakthrough Therapy , Antibacterial Agents , New Compounds , Preclinical Data , Preclinical Development , Testing Methods , Incl Assay Validation , Comparative Studies , Relations Contacts ,